drugset / Trial / NCT01873079

PPI for Prevention of Post-sphincterotomy Bleeding

NCT01873079

Phase 3 Completed 185 enrolled The University of Hong Kong
RandomizedParallel-groupOpen-labelPrevention

Summary

Endoscopic biliary sphincterotomy is a common and important procedure for biliary access and therapy during endoscopic retrograde cholangiopancreatography (ERCP). Bleeding is one of the important complications related to sphincterotomy. This study determines the role of proton pump inhibitor (PPI) in preventing post-sphincterotomy bleeding in patients undergoing ERCP and sphincterotomy.

Timeline

Start
2013-04
Primary completion
2016-03
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esomeprazole Small molecule 40 mg

Indications